SK284756B6 - Farmaceutický prípravok pre inhalátory meranej dávky s hnacím plynom, kde hnacím plynom je fluóruhľovodík, ktorý obsahuje kombináciu dvoch alebo viacerých aktívnych látok - Google Patents

Farmaceutický prípravok pre inhalátory meranej dávky s hnacím plynom, kde hnacím plynom je fluóruhľovodík, ktorý obsahuje kombináciu dvoch alebo viacerých aktívnych látok Download PDF

Info

Publication number
SK284756B6
SK284756B6 SK1939-2000A SK19392000A SK284756B6 SK 284756 B6 SK284756 B6 SK 284756B6 SK 19392000 A SK19392000 A SK 19392000A SK 284756 B6 SK284756 B6 SK 284756B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical preparation
preparation according
propellant
acid
stabilizer
Prior art date
Application number
SK1939-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK19392000A3 (sk
Inventor
Daniel Patrick Mcnamara
George A. Destefano
Original Assignee
Boehringer Ingelheim Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284756(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharmaceuticals, Inc. filed Critical Boehringer Ingelheim Pharmaceuticals, Inc.
Publication of SK19392000A3 publication Critical patent/SK19392000A3/sk
Publication of SK284756B6 publication Critical patent/SK284756B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1939-2000A 1998-06-18 1999-06-08 Farmaceutický prípravok pre inhalátory meranej dávky s hnacím plynom, kde hnacím plynom je fluóruhľovodík, ktorý obsahuje kombináciu dvoch alebo viacerých aktívnych látok SK284756B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
PCT/US1999/012785 WO1999065464A1 (en) 1998-06-18 1999-06-08 Pharmaceutical formulations for aerosols with two or more active substances

Publications (2)

Publication Number Publication Date
SK19392000A3 SK19392000A3 (sk) 2001-07-10
SK284756B6 true SK284756B6 (sk) 2005-11-03

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1939-2000A SK284756B6 (sk) 1998-06-18 1999-06-08 Farmaceutický prípravok pre inhalátory meranej dávky s hnacím plynom, kde hnacím plynom je fluóruhľovodík, ktorý obsahuje kombináciu dvoch alebo viacerých aktívnych látok

Country Status (33)

Country Link
EP (1) EP1087750B1 (sr)
JP (1) JP2003522102A (sr)
KR (1) KR100600423B1 (sr)
CN (1) CN1161104C (sr)
AR (1) AR019690A1 (sr)
AT (1) ATE253896T1 (sr)
AU (1) AU759222B2 (sr)
BG (1) BG65252B1 (sr)
BR (1) BR9911351A (sr)
CA (1) CA2335065C (sr)
CO (1) CO5070580A1 (sr)
CZ (1) CZ300910B6 (sr)
DE (1) DE69912781T2 (sr)
DK (1) DK1087750T3 (sr)
EE (1) EE04450B1 (sr)
ES (1) ES2211108T3 (sr)
HK (1) HK1037974A1 (sr)
HR (1) HRP20000867B1 (sr)
HU (1) HU229064B1 (sr)
ID (1) ID27554A (sr)
IL (2) IL140353A0 (sr)
ME (1) ME00838B (sr)
MY (1) MY121073A (sr)
NO (1) NO329416B1 (sr)
NZ (1) NZ509418A (sr)
PL (1) PL193695B1 (sr)
PT (1) PT1087750E (sr)
RS (1) RS49977B (sr)
RU (1) RU2218152C2 (sr)
SK (1) SK284756B6 (sr)
TR (1) TR200003721T2 (sr)
TW (1) TW528606B (sr)
WO (1) WO1999065464A1 (sr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
AU7026800A (en) 1999-09-11 2001-04-17 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
JP2003514841A (ja) * 1999-11-23 2003-04-22 グラクソ グループ リミテッド サルメテロールの医薬製剤
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
IL152955A0 (en) 2000-05-22 2003-06-24 Chiesi Farma Spa Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
EP1661570A3 (en) 2001-09-18 2012-10-24 Nycomed Danmark ApS Compositions comprising ipatropium and xylometazoline for treatment of the common cold
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
JP2008546634A (ja) * 2005-03-16 2008-12-25 ハネウェル・インターナショナル・インコーポレーテッド 医薬送達製剤、デバイス及び方法
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2010105776A1 (en) 2009-03-17 2010-09-23 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011084316A2 (en) 2009-12-16 2011-07-14 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
JP6526057B2 (ja) 2014-05-07 2019-06-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ及び容器
HUE064131T2 (hu) 2014-05-07 2024-03-28 Boehringer Ingelheim Int Egység, porlasztó és eljárás
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
PL177078B1 (pl) * 1992-12-09 1999-09-30 Boehringer Ingelheim Pharma Preparaty roztworów aerozolowych
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Also Published As

Publication number Publication date
CO5070580A1 (es) 2001-08-28
HU229064B1 (en) 2013-07-29
DK1087750T3 (da) 2004-01-26
BG105033A (en) 2001-09-28
TW528606B (en) 2003-04-21
JP2003522102A (ja) 2003-07-22
IL140353A0 (en) 2002-02-10
BG65252B1 (bg) 2007-10-31
NO329416B1 (no) 2010-10-18
CN1161104C (zh) 2004-08-11
ATE253896T1 (de) 2003-11-15
CN1307470A (zh) 2001-08-08
NO20006318D0 (no) 2000-12-12
AU759222B2 (en) 2003-04-10
AU4552199A (en) 2000-01-05
EP1087750A1 (en) 2001-04-04
TR200003721T2 (tr) 2001-06-21
RS49977B (sr) 2008-09-29
NO20006318L (no) 2001-01-30
YU80000A (sh) 2003-04-30
HRP20000867B1 (en) 2010-10-31
DE69912781T2 (de) 2004-10-21
MY121073A (en) 2005-12-30
PL345685A1 (en) 2002-01-02
CZ300910B6 (cs) 2009-09-09
KR100600423B1 (ko) 2006-07-13
KR20010072621A (ko) 2001-07-31
WO1999065464A1 (en) 1999-12-23
RU2218152C2 (ru) 2003-12-10
PL193695B1 (pl) 2007-03-30
SK19392000A3 (sk) 2001-07-10
ME00838B (me) 2008-09-29
ID27554A (id) 2001-04-12
CA2335065A1 (en) 1999-12-23
BR9911351A (pt) 2001-03-13
PT1087750E (pt) 2004-02-27
NZ509418A (en) 2003-06-30
AR019690A1 (es) 2002-03-13
EP1087750B1 (en) 2003-11-12
EE200000759A (et) 2002-04-15
HK1037974A1 (en) 2002-03-01
IL140353A (en) 2006-09-05
CZ20004750A3 (en) 2001-05-16
EE04450B1 (et) 2005-04-15
HRP20000867A2 (en) 2001-10-31
CA2335065C (en) 2008-06-03
HUP0104734A2 (hu) 2002-05-29
ES2211108T3 (es) 2004-07-01
DE69912781D1 (de) 2003-12-18
HUP0104734A3 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
SK284756B6 (sk) Farmaceutický prípravok pre inhalátory meranej dávky s hnacím plynom, kde hnacím plynom je fluóruhľovodík, ktorý obsahuje kombináciu dvoch alebo viacerých aktívnych látok
US6423298B2 (en) Pharmaceutical formulations for aerosols with two or more active substances
KR100794060B1 (ko) 에어로졸 약제 조성물
JP4380802B2 (ja) 医薬用エアロゾル組成物
RU2294737C2 (ru) Медицинские аэрозольные составы
WO2005004844A1 (en) Hfc solution formulations containing an anticholinergic
CN1069191C (zh) 使用聚氧乙烯丙三基油酸酯类的压气包装
SK281519B6 (sk) Farmaceutický aerosólový prostriedok
SK76095A3 (en) Aerosol solution formulation and a stabilization method thereof
EP2040670A1 (en) Stable aerosol pharmaceutical formulations
SK16062002A3 (sk) Farmaceutický prostriedok na použitie v aerosólovom inhalátore s odmeranou dávkou a spôsob jeho výroby
UA73721C2 (en) Pharmaceutical formulations for aerosols with at least two or more active substances
KR0175164B1 (ko) 에어로졸 약물 제제
MXPA00012388A (en) Pharmaceutical formulations for aerosols with two or more active substances
DE19908210A1 (de) Stabile, FCKW-freie Arzneimittelaerosole
DE19842963A1 (de) Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
NZ243056A (en) Aerosol formulation containing a medicament, tetrafluoroethane and isopropyl myristate
WO2008047239A2 (en) Stable aerosol pharmaceutical formulations